biosimilaarit

Biosimilaarit, also known as biosimilars, are biological products that are highly similar to already approved biological reference products. These products are designed to provide the same clinical benefit and be switched between without loss of efficacy or safety. Biosimilars are typically used in the treatment of chronic conditions such as rheumatoid arthritis, multiple sclerosis, and cancer. They are produced using similar manufacturing processes and contain the same active ingredients as the reference product, but they are not identical due to minor differences in certain aspects of their composition. Biosimilars are subject to rigorous testing and regulatory approval processes to ensure their quality, safety, and efficacy. The use of biosimilars can help to increase access to affordable and effective treatments, particularly in low- and middle-income countries. The global biosimilars market has been growing rapidly in recent years, driven by the increasing demand for affordable healthcare and the patent expiration of many biological reference products.